INMB EBITDA Growth
Inmune Bio Inc · EBITDA Growth
INMB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported53.34%period ending
INMB TTM EBITDA YoY % (-100.00% → 53.34%)
Year-over-year change
High-resolution chart · PNG
INMB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 53.3357% | |
| 38.4351% | |
| 29.8341% | |
| 18.6641% | |
| -34.2122% | |
| -109.0639% | |
| -393.9911% | |
| -32,836% | |
| -32,263.3333% | |
| -100.6048% | |
| -100.8028% | |
| -100% | |
| -100% | |
| 228.2753% | |
| 268.4598% | |
| 316.1486% | |
| 209.0418% | |
| -148.0283% | |
| -2.4437% | |
| 51.9644% | |
| -80.288% | |
| -1,029,645.9588% | |
| -2,271,515.7343% | |
| -1,601,366.0584% | |
| -10,076,286.9565% | |
| 99.0536% | |
| 9,433.3333% | |
| -203.0075% | |
| -99.9847% | |
| -99.6819% | |
| -99.997% |